Related by context. All words. (Click for frequent words.) 78 personalized dendritic 76 DCVax R Prostate 72 investigational hepatitis B 71 MKC# MT 70 human IgG1 monoclonal 70 GVAX ® 70 SinuNase TM 70 dose intramuscular 69 acyclovir Lauriad R 69 Adjuvanted 69 Pancreas Cancer Vaccine 69 GVAX R 68 HEPLISAV hepatitis B 68 administered intramuscularly 68 HEPLISAV TM hepatitis B 68 recombinant hepatitis B 68 Initiates Enrollment 68 Personalized Immunotherapy 68 telomerase therapeutic 68 highly purified pasteurized 68 molecular imaging radiopharmaceutical 67 acetonide FA 67 essential thrombocythemia ET 67 humanized therapeutic 67 BiTE R 67 pharmacogenomic translational research 67 MCSP respectively 67 antibody MAb 67 using VIAdel TM 67 Begins Dosing 67 CTAP# Capsules 67 trivalent seasonal flu 67 oncolytic virus therapies 66 GRNVAC1 66 Initiates Phase II 66 monoclonal antibody conjugated 66 Completes Patient Enrollment 66 muscarinic receptor agonist 66 lintuzumab SGN 66 candidate deforolimus 66 SynCon TM DNA 66 non nucleoside inhibitor 66 Phase #b/#a clinical 66 hypoxia activated prodrug 66 AdVac ® 66 anti botulism antibody 66 AAG geldanamycin analog 66 ALTROPANE R 66 Combination REOLYSIN R 66 humanised monoclonal antibody 66 Varicella chicken pox 66 MOVIPREP R 66 hyaluronidase enzyme 66 Chimigen TM 66 PORxin TM platforms 65 PDX pralatrexate 65 Achieves Primary Endpoint 65 Nicotine Conjugate Vaccine 65 IMA# 65 CD# CEA 65 MAGE A3 ASCI 65 intranasal formulation 65 PANVAC VF 65 IMPDH inhibitor 65 orally administered inhibitor 65 thrombin component 65 phase III isavuconazole 65 Peginterferon alfa 2b 65 antigen rPA anthrax 65 injectable influenza 65 Phase 2a clinical trials 65 investigational monoclonal antibody 65 IMiDs ® compound 65 anti CD3 monoclonal 65 Initiate Clinical Trial 65 Initiates Phase III 65 virus HCV protease inhibitor 65 Alfacell proprietary ribonuclease 65 targeted radiotherapeutic 65 delivers fluocinolone acetonide FA 65 Initiates Clinical Trial 65 IMiDs ® 65 XL# anticancer compounds 65 recombinant subunit vaccine 65 candidate AQ4N 65 RhuDex ® 65 Vaxfectin TM formulated 65 developing Zerenex ferric 65 immuno therapeutic 65 XOMA 3AB 65 myelodysplastic myeloproliferative diseases 65 Therapeutic Competitors Companies 65 Nasal spray flu 65 BiovaxID TM 65 NicVAX TM 65 TELINTRA R 65 Gonal f ® 65 Luveris R Ovidrel R 65 OMP #R# 65 SinuNase ™ 65 relapsed leukemia 65 novel VDA molecule 65 including eniluracil ADH 65 Novavax VLP vaccine 65 AstraZeneca AZN.L 行情 64 PORxin TM 64 Solazed TM 64 FOLOTYN ® 64 ALN PCS 64 2 methoxyestradiol 64 Gonal f R 64 Vitrasert R 64 Crofelemer budesonide foam 64 Pruvel TM 64 Zalypsis 64 rALLy clinical trial 64 TNFerade ™ 64 Presents Positive 64 pipeline GlycoPEG GCSF 64 oral ghrelin agonist 64 TBC# 64 SynCon ™ DNA 64 ionotropic glutamate receptor antagonists 64 PAION AG ISIN 64 MVA# 64 IL# PE#QQR 64 CYT# potent vascular disrupting 64 Submits Biologics License Application 64 CEL SCI Phase III 64 Viread tenofovir disoproxil fumarate 64 polysaccharide polymer 64 Immunotherapeutic 64 phase IIb clinical 64 oral prodrug 64 Shigatoxin producing E. coli 64 Inhalation Powder 64 using Crucell PER.C6 64 Initiates Clinical 64 hepatitis B immune globulin 64 MEK Inhibitor 64 sapacitabine CYC# 64 Successfully Completes Phase 64 Onalta ™ 64 selective modulator 64 apricitabine ATC 64 refractory chronic lymphocytic 64 Proellex TM 64 INSPIRE Trial Phase III 64 Maxy G# 64 cytomegalovirus immune globulin 64 non porcine pancreatic 64 Phase 2b Clinical Trial 64 trivalent seasonal influenza 64 huC# DM4 64 5 fluorouracil leucovorin 64 mitogen activated ERK kinase 64 SAR# [004] 64 TKM PLK1 64 dasatinib Sprycel ® 64 adalimumab Humira 64 PRN FDA Approves 64 Phase Ib IIa 64 immunotherapeutic agent 64 novel emulsion formulation 64 CCR5 mAb 64 topically applied SEPA 64 relapsed MM 64 Liprotamase 64 Intercell Japanese Encephalitis 64 genetically engineered recombinant protein 64 purified inactivated vaccine 63 IMiDs R 63 HEPLISAV TM 63 SPL# Gel vaginal microbicide 63 OMP #M# 63 Pharmacokinetics PK 63 pan histone deacetylase 63 Panzem R 63 agonistic human 63 G#DT 63 TOCOSOL Camptothecin 63 commercializing oxidized glutathione 63 HCV polymerase 63 VEGFR2 inhibitor 63 XmAb ® 63 approved incretin mimetic 63 TRIOLEX HE# APOPTONE HE# 63 PER.C6 r 63 Staphylococcus aureus Polysaccharide Conjugate 63 forodesine hydrochloride 63 candidate epratuzumab 63 Hematide TM 63 Telik logo TELINTRA 63 PROVENGE ® 63 mertansine 63 Intravenous Human 63 Prodarsan R 63 MVA BN R 63 Tumour Vascular Disrupting Agent 63 subcutaneous formulation 63 TRACON Pharmaceuticals 63 kidney urologic 63 trivalent influenza vaccine 63 HGS ETR1 mapatumumab 63 PEGylated anti 63 OvaRex R 63 cutaneous T 63 non splenectomized 63 Receives Orphan Drug Designation 63 Phase IIb Trial 63 evaluating tivozanib 63 Panzem R NCD 63 molecular therapeutics immunotherapies 63 ospemifene 63 recurrent metastatic ovarian cancer 63 ocular formulation 63 Dementia Related Psychosis 63 virosome 63 OTCBB OHRP 63 TRO# 63 Inotek Pharmaceuticals Corporation 63 GW# [003] 63 gastro intestinal inflammation 63 #I TM# 63 IgG1 monoclonal antibody 63 PRNewswire Sinovac Biotech 63 Pentacel R 63 forodesine 63 intradermal injections 63 vapreotide acetate 63 CYT# NicQb 63 Pegloticase 63 Vascular Disrupting Agent 63 Zemiva TM 63 GlaxoSmithKline MedImmune 63 Novavax VLP 63 Inc. ProMetic www.prometic.com 63 lenalidomide Revlimid R 63 multicenter Phase III 63 targets Galectin receptors 63 include Healive TM 63 HuMax TAC 63 receptor inhibiting monoclonal 63 successfully commercialize Iluvien 63 Phase III multicenter 63 MVA BN 63 Inc. NASDAQ BPAX 63 interferon gamma 1b 63 Empatic TM 63 Hsp# Inhibitor 63 compound ISA# 63 Bilive TM 63 AFREZZA TM 63 pharmacologically active isomer 63 ALN HPN 63 Presents Preclinical 63 Anflu TM 63 R Saizen R 63 vinca alkaloid 63 compound perifosine 63 Panenza 63 Aganocide 63 TransVax tm 63 Budesonide foam crofelemer 63 rotavirus shingles 62 Cloretazine ® 62 Files IND 62 include Altastaph TM 62 HepaGam B 62 Vicriviroc 62 Nasdaq ENZN 62 trivalent inactivated influenza 62 Merck Suspends Lobbying 62 oropharyngeal candidiasis OPC 62 OvaRex ® MAb 62 Neulasta R 62 personalized cellular immunotherapy 62 CCR5 antagonist 62 Aflibercept 62 4SC AG ISIN DE# 62 candidate CRLX# 62 therapeutic monoclonal antibody 62 personalized immunotherapy 62 pan HDAC inhibitor 62 severe hypercholesterolemia 62 administered intranasally 62 Sebelius Ample 62 HuCNS SC ® 62 INxin TM 62 fully liquid pentavalent 62 LymphoStat B TM 62 Elotuzumab 62 Bacterin develops manufactures 62 Romidepsin 62 IAP inhibitor 62 vivo toxicology 62 candidate TNFerade biologic 62 imatinib Gleevec ® 62 product BioThrax ® 62 Allovectin 7 62 Meets Primary Endpoint 62 nasal calcitonin product 62 Iluvien ® 62 oral nucleoside analogue 62 P#X# antagonist 62 MyVax ® 62 Glaxo cervical cancer 62 Phase IIb clinical trials 62 Diamyd R 62 trastuzumab DM1 T DM1 62 Tibotec Therapeutics division 62 CA9 SCAN 62 TÎ ² 4 62 Therapeutic Competitors companiesandmarkets.com adEgemonye 62 candidates Azedra TM 62 PNP inhibitor 62 Corixa Corporation 62 Inc. www.micromet inc.com 62 Emtriva Viread 62 Doripenem 62 next generation URAT1 62 Pivotal Phase III 62 accumulate preferentially 62 telomerase inhibitor drug 62 Focetria 62 evaluating picoplatin 62 midstage clinical 62 vomiting fever headache 62 metaglidasen 62 Japanese Encephalitis vaccine 62 diagnosed Glioblastoma multiforme 62 DEB# 62 Amigal TM 62 valtorcitabine 62 XL# XL# 62 ASE SVA 62 ChronVac C R 62 generation Hsp# inhibitor 62 Sanofi Pasteur Menactra 62 Initiates Phase 2b 62 Sudhir Agrawal D.Phil 62 AMEX RGN 62 GSK cervical cancer 62 PGL# 62 Allovectin 7 R 62 Provectus Pharmaceuticals specializes 62 oral dual endothelin 62 product TNFerade TM 62 Phase III Trials 62 oxybutynin ATD TM 62 B Anflu R 62 MKC# MKC# PP 62 reslizumab 62 selective phosphodiesterase 62 reformulates existing FDA 62 sapropterin dihydrochloride Phase 62 TLK# 62 Hedgehog Pathway Inhibitor 62 Submits Response 62 investigational humanized monoclonal antibody 62 Initiate Phase 62 Cotara ® 62 candidate ridaforolimus 62 Atripla combines 62 novel therapeutic antibodies 62 Luteinizing Hormone Releasing Hormone 62 Phase Ib clinical trials 62 oral proteasome inhibitor 62 aerosolized AAT 62 class anticancer quinolone 62 Phase IIb trials 62 Matrix Phase 2b 62 Tβ4 synthetic copy 62 albiglutide 62 R lenalidomide 62 Roche OTC RHHBY 62 H#N# VLP vaccine 62 phase IIb trial 62 generation purine nucleoside 62 candidate iSONEP TM 62 PrevOnco 62 Auxilium transmucosal film 62 Ovitrelle R Serostim 62 erlotinib Tarceva ® 62 Selective Electrochemical Tumor Ablation 62 OAB overactive bladder 62 include PLX IBD 62 seliciclib CYC# 62 CINTREDEKIN BESUDOTOX 62 Genentech sanofi aventis 62 Aryplase 62 Allovectin 7 r 62 novel immunomodulatory 62 revaccinate according 62 candidate XP# 62 Simulect 62 GLP toxicology studies 62 OTCBB HNAB 62 Investigational Oral 62 LEUKINE 62 Modrenal R 62 adjuvanted H#N# 62 YONDELIS 61 gets USFDA nod 61 DURIN TM 61 subcutaneous immunoglobulin 61 PEGylated irinotecan 61 KRN# 61 multicenter Phase II 61 Nasdaq HALO 61 oral dihydropyrimidine dehydrogenase DPD 61 NASH Huntington 61 trial evaluating PRX# 61 HepaGam B TM 61 ChronVac C 61 PEG SN# 61 Files Investigational 61 MyVax R 61 Manja Bouman CEO 61 treat chronic sinusitis 61 clinical trials dacetuzumab SGN 61 ZADAXIN ® 61 Bacille Calmette Guérin BCG 61 Annamycin 61 Solazed 61 Panzem NCD 61 GeoVax HIV AIDS 61 nucleotide analogue 61 LymphoStat B belimumab 61 include Phenoptin TM 61 GlaxoSmithKline Biologicals GSK Biologicals 61 sodium thiosulfate STS 61 Naive Patients 61 aripiprazole Abilify 61 HQK 61 HCV RNA polymerase 61 PEGylated interferon 61 IAP inhibitors 61 Genasense ® 61 BENLYSTA TM 61 diagnosed glioblastoma 61 Ecallantide 61 receptor tyrosine kinase inhibitor 61 CERVARIX 61 Phase III Clinical Trial 61 targeted antifolate 61 selective kinase inhibitor 61 alfa 2a 61 Anturol ® 61 vaccine GRNVAC1 61 Bacillus Calmette Guerin 61 DPX Survivac 61 Complicated Skin 61 VISICOL R 61 Onalta TM 61 rxRNA 61 Vertex telaprevir 61 Elagolix 61 Pruvel ™ 61 PROVENGE sipuleucel T 61 alvespimycin 61 catheter occlusion 61 Albuferon TM 61 leading oral taxane 61 autologous cellular immunotherapy 61 Polysaccharide Diphtheria Toxoid Conjugate 61 novel immunotherapies 61 Rebif ® 61 THR beta agonist 61 BioSante Pharmaceuticals Announces 61 Empatic ™ 61 SPRYCEL ® 61 Locteron ® 61 Preclinical studies suggest 61 Reports Preclinical Data 61 Presents Preclinical Data 61 recombinant PSMA vaccine 61 OncoVex 61 midstage studies 61 Submits IND 61 Sanofi Pasteur Fluzone 61 NU# direct 61 RiVax 61 PROSTASCINT R 61 Protexia R 61 investigational antiplatelet agent 61 Vidaza azacitidine 61 Nitazoxanide 61 trastuzumab Herceptin R 61 Opterone R 61 Factor VIIa 61 hoFH 61 Vidaza R 61 selective immunoproteasome inhibitor 61 prepandemic 61 administered subcutaneously 61 developing Zerenex TM 61 molecular chaperone regulation 61 LAB CGRP 61 chimeric monoclonal antibody 61 REGN# 61 topical gel formulation 61 include Healive 61 liposomal formulation 61 FUSILEV enhances 61 product candidate Lpathomab 61 TNFerade TM 61 Xcytrin R 61 VitiGam 61 QNEXA ® 61 MT#/MEDI-# 61 ADP receptor antagonist 61 5 HT3 antagonist 61 Sebivo 61 Oracea TM 61 Nasdaq IDIX biopharmaceutical 61 Kosan dependence 61 Sanofi Pasteur ALVAC canary 61 Zavesca R 61 Zorbtive TM 61 Triapine 61 metastatic castrate resistant 61 Nasdaq ABII 61 cyclophilin inhibitors 61 myeloid metaplasia 61 Vascular Wrap TM 61 patented DepoVax TM 61 demonstrated antitumor activity 61 Lovaxin C 61 protein tyrosine phosphatase 1B 61 Locteron exclusively 61 HepeX B 61 Vytorin combines 61 Civacir 61 investigational pharmacologically unique 61 midstage trials 61 pancreatic enzyme replacement 61 Vicinium TM 61 XL# XL# XL# XL# 61 MKC# 61 infectious diseases autoimmune diseases 61 Neuvenge 61 purine nucleoside phosphorylase PNP 61 vosaroxin 61 FACTIVE R gemifloxacin 61 valent conjugate vaccine 61 trivalent seasonal influenza VLP 61 orBec ® oral beclomethasone 61 markets HP Acthar 61 NS5b 61 hypereosinophilic syndrome 61 Bezielle 61 Fx #A 61 Elvitegravir 61 systemic RNAi therapeutic 61 chickenpox varicella 61 etanercept Enbrel 61 Gamunex C 61 muscarinic receptor agonists 61 AEG# 61 pralatrexate injection folate analogue 61 Cetrorelix 61 dihydrochloride Tablets 61 Bradmer Pharmaceuticals 61 OTC BB PVCT http:/www.pvct.com 61 dirucotide MBP# 61 phase IIb study 61 TKB# 61 HYVISC ® treatment 61 Panflu TM Sinovac 61 isoform selective 61 Toxoid 61 Metastatic Melanoma 61 Oncophage vitespen 61 Genasense ® oblimersen 61 SIX RO ROG 61 compound KOS 61 5 lipoxygenase inhibitor 61 Medidur TM FA 61 hepatitis C HCV 61 cromolyn sodium 61 IRX 2 61 MSCRAMM ® 61 proprietary intranasal insulin 61 selective estrogen receptor modulator 61 treatment naive genotype 61 GTC recombinant human 61 tumors GIST 61 candidates Azedra 61 containing abacavir 61 Solazed ™ 61 Albugon 61 Submits NDA 61 oral ferric iron 61 lucinactant 61 CYT# vascular disrupting 61 KRYSTEXXA TM pegloticase 61 NeuroSTAT ® 61 candidate REP# 60 Myocet 60 VivaGel ™ 60 Maribavir 60 IMVAMUNE TM 60 stage antibody MT# 60 MTP inhibitor 60 CRMD# 60 CTAP# Injection 60 AstraZeneca PLC AZN AZN.LN 60 Raptiva R 60 cardio renal 60 Zoraxel 60 RTP #i 60 lung pancreatic 60 Anthrax Vaccine Adsorbed 60 targeting Inflammatory Bowel 60 Prochymal TM 60 vinorelbine tartrate 60 Piperacillin 60 Temsirolimus 60 Pradefovir 60 Demonstrates Significant 60 Copegus ribavirin 60 fusion enhancers 60 anti PlGF 60 HCV polymerase inhibitors 60 methylnaltrexone bromide 60 HEPLISAV ™ 60 Randomized Phase 60 potent suppressor 60 Hualan 60 CCR9 antagonist 60 Friedreich Ataxia FRDA 60 Testosterone MDTS ® 60 Luveris 60 NASDAQ SCRX specialty 60 BARACLUDE R 60 recombinant biopharmaceutical 60 IV acetaminophen 60 NOX E# 60 Cethrin R 60 BUPHENYL R 60 itraconazole Sporanox 60 LEVADEX ™ 60 PEGylated Fab fragment 60 Acellular Pertussis 60 Rhucin ® recombinant 60 CDP# 60 initiated Phase Ib 60 Bilive TM combined 60 treat nicotine addiction 60 TLR9 agonist 60 TORISEL TM 60 Sapacitabine 60 trastuzumab DM1 60 intravesical instillation 60 de novo kidney transplant 60 orBec R oral beclomethasone 60 Syndax Pharmaceuticals Inc. 60 novel histone deacetylase 60 Emergent marketed 60 brivanib 60 Argatroban 60 CEQ# 60 Plavix clopidogrel bisulfate 60 ThermoDox R 60 Pentavalent 60 small molecule tyrosine 60 Receives Positive Opinion 60 Recombinant Human 60 Granted Orphan Drug 60 Ribavirin causes 60 BLP# 60 oral ridaforolimus 60 Azacitidine 60 Phase IIIb clinical 60 NASDAQ SNTA 60 novel DACH platinum 60 Clevudine 60 Bacillus Calmette Guérin BCG 60 OTCBB HXBM developer 60 immunotoxin 60 recurrent glioblastoma multiforme 60 prescribed proton pump 60 Familial Adenomatous Polyposis FAP 60 commercialize CorMedix drug 60 ATRA IV 60 prokinetic agent 60 avian influenza viral infections 60 mGluR5 NAM 60 iii GTx 60 Valortim TM 60 Enrolls First 60 Protexia ® 60 MVA HPV IL2 60 non alcoholic steatohepatitis 60 Xeloda ® 60 Augment TM 60 refractory gout 60 adecatumumab MT# 60 Locteron combines 60 signal detection CTSD 60 Theratope 60 polycythemia vera essential thrombocythemia 60 rHuPH# recombinant human 60 thiazolides 60 Xcellerated T Cells 60 Phase III Pivotal 60 Quinamed 60 Nasdaq CYCC Nasdaq CYCCP 60 inhalable flu 60 investigational oral hepatitis C 60 FluCide 60 RANK Ligand inhibitor 60 metformin XR 60 cisplatin gemcitabine 60 Omacetaxine 60 Ophena TM 60 humanized monoclonal 60 MMR Measles Mumps Rubella 60 induced macular edema 60 Mg Usa 60 Soliris TM eculizumab 60 nasally delivered 60 oral rivaroxaban 60 Tesetaxel 60 Ostabolin C TM 60 SUCCEED trial 60 developing TB4 60 LEP ETU 60 Brentuximab Vedotin SGN 60 Therapeutic Vaccine 60 Altastaph 60 PEG irinotecan 60 im peramivir 60 investigational immunotherapy 60 Asentar TM 60 Nasdaq PGNX today 60 JAK2 inhibitor 60 FDA APPROVES 60 telaprevir VX 60 SAR# [002] 60 development peramivir neuraminidase 60 CELVAPAN H#N# 60 Vaxfectin 60 radiolabeled TM# 60 Pandemic Influenza Vaccine 60 factor TNF receptor 60 Haemophilus b Conjugate 60 Receives Approvable Letter 60 sodium glucose cotransporter 60 Announces Tentative Approval 60 faropenem medoxomil 60 Nanobody R 60 Kit CD# positive 60 pioglitazone hydrochloride 60 COLAZAL R 60 By JENNIFER LEARN 60 REG1 Anticoagulation System 60 delta opioid receptor 60 HIV treatments Reyataz 60 Edurant 60 ELACYT 60 DCVax R 60 PROLOR Biotech Inc. 60 clinical trials SGN 60 tubulin inhibitor 60 JAK inhibitor 60 Patients Treated With 60 Martin Nicklasson CEO 60 AdVac 60 Survivin antagonist 60 acellular pertussis DTaP 60 systemically administered 60 Belimumab 60 Wafer polifeprosan 60 CMV vaccine 60 oncologic diseases 60 HCV NS5B polymerase 60 OTCBB ADXS 60 epoetin alpha 60 TO AVOID PREGNANCY WHILE 60 Virosome Biologicals 60 Veronate R 60 Canvaxin TM 60 Onalta 60 dihydrofolate reductase 60 SYCREST 60 Nasdaq MITI biopharmaceutical 60 intradermal injection 60 Vitaxin 60 mda 7 60 TELINTRA 60 acadesine 60 investigational integrase inhibitor 60 GLOBE NEWSWIRE Cyclacel Pharmaceuticals 60 Oral Calcitonin 60 immunomodulatory therapy 60 Inc Therapeutic Competitors 60 IV Busulfex 60 Gentamicin Surgical Implant 60 Nutra Pharma wholly owned 60 Intercell vaccine 60 Sustiva efavirenz 60 novel L DOS# 60 dermatology biopharmaceutical company 60 drug pipeline TAFA# 60 Lispro 60 nasally administered 60 acyclovir valacyclovir 60 ongoing Phase 1b 60 intra nasal 60 Archexin 59 oral rotavirus vaccine 59 castrate resistant prostate cancer 59 AQ4N 59 Aganocide ® 59 Pharma Merck Serono 59 #mg ATC 59 Daclizumab 59 FluINsure 59 Cytogen marketed 59 Amrubicin 59 BEMA Granisetron 59 proprietary attenuated Listeria 59 novel synthetic PEGylated 59 overactive bladder AA# 59 Neupogen ® 59 multicenter Phase 59 non peptidic protease 59 Troxatyl 59 oral methylnaltrexone 59 orally dosed 59 RNA antagonists 59 CRD5 59 CTA# Injection 59 rusalatide acetate 59 PRT# 59 antimitotic 59 estrogen receptor beta agonist 59 IG HCR ;) CO 59 EV# vaccine 59 BRIM2 59 peptidic compound 59 Phase Ib II 59 please visit http:/www.vandapharma.com 59 liver resection surgeries 59 PrevOnco ™ 59 sorafenib tablets 59 MenACWY 59 Androxal TM 59 Nabi HB R 59 Poly ICLC 59 Immune globulin 59 Phase #b/#a trial 59 Mg Uk 59 EGS# 59 COPEGUS therapy 59 virus HCV infection 59 Investigational Treatment 59 Taiho Pharmaceutical 59 R sorafenib tablets 59 treats Gaucher disease 59 INS# [001] 59 candidate ATHX 59 REMUNE R 59 nano particle tumor suppressor 59 orally inhaled migraine 59 5 lipoxygenase activating 59 technology visit http:/www.genmab.com 59 Pafuramidine 59 Oxytrex TM 59 Japanese Encephalitis Vaccine 59 Vertex hepatitis C 59 RELOVAIR ™ 59 investigational protease inhibitor 59 Vascugel 59 shingles vaccine Zostavax 59 VLP influenza 59 Saquinavir 59 synthetic peptide containing 59 developed preclinically 59 platinum chemotherapeutic 59 TRANSDUR ® 59 vaccine Synflorix 59 amantadine rimantadine 59 FUSILEV ® 59 markets biosurgical 59 Pivotal Clinical Trial 59 ELND-#/AZD-# 59 RECOTHROM ® 59 Staphylococcus aureus Immune Globulin 59 CDK cyclin dependent 59 Inc. NASDAQ HEPH 59 docetaxel Taxotere R 59 Fludara ® 59 taxane resistant 59 HepeX B TM 59 lumiliximab 59 Myelodysplastic Syndrome MDS 59 Unigene nasal calcitonin 59 TSX BSY 59 selective androgen receptor modulator 59 drug conjugate ADC 59 Humenza 59 Launches Generic Version 59 intravesical infusion therapy 59 intranasal mist 59 Monopril 59 Copegus ® 59 valent adsorbed 59 riboflavin vitamin B2 59 oral immunomodulatory 59 Diamyd ® 59 Phase #/#a trial 59 Generx TM 59 Tech DVAX 59 Corp. Nasdaq BSTC 59 pegylated interferon alfa 2a 59 miconazole MBT 59 ORENCIA ® 59 Inc. OTCBB ALRX 59 MT# MEDI 59 Granulocyte Colony Stimulating Factor 59 Angiotensin Converting Enzyme 59 Rotarix ® 59 markets COLAZAL 59 IMC #B 59 LHRH antagonist 59 Pivotal Trial 59 docetaxel Taxotere ® 59 phenylalanine ammonia lyase 59 Inc. Nasdaq NVAX 59 novel peptide 59 elacytarabine 59 GRNOPC1 contains 59 Cintredekin Besudotox 59 cMET 59 topically administered 59 humanized monoclonal antibodies 59 valent pneumococcal conjugate vaccine 59 diagnosed Ph + 59 live attenuated intranasal 59 pertussis tetanus 59 galiximab 59 CYP#A# CYP#D# 59 recombinant polyclonal antibodies 59 volociximab 59 Angiocept 59 MAXY alpha 59 GRN# 59 tramiprosate Alzhemed TM 59 Phase #/#a 59 t2cure GmbH 59 Cloretazine 59 acid phosphatase PAP 59 drug ISA# 59 oral beclomethasone dipropionate 59 PDE4 inhibitor 59 Arzerra ofatumumab 59 Glatiramer Acetate 59 Ozarelix 59 PI3K/Akt pathway inhibitor 59 Nektar proprietary 59 HyperAcute 59 NYSE Amex PBTH 59 dose escalation clinical 59 rheumatoid arthritis psoriatic arthritis 59 Twinrix 59 developing ACAPODENE 59 lymphoid malignancies 59 Voreloxin 59 OTCBB DORB 59 oral isotype selective HDAC 59 Onconase 59 DMAG 59 histone deacetylase HDAC 59 OTCBB NRGX 59 FS Antihemophilic Factor Recombinant 59 Inc. Nasdaq BNVI 59 HDL Selective Delipidation 59 infused intravenously 59 Onco TCS 59 2A receptor agonist 59 Cleviprex TM clevidipine 59 nucleoside analog 59 ACIs 59 OncoVEX 59 Æterna Zentaris Inc. 59 Oral NKTR 59 Nasdaq DVAX 59 Pegasys peginterferon alfa 2a 59 butyrylcholinesterase 59 inactivated poliovirus 59 Presents Positive Preclinical 59 cetuximab Erbitux R 59 arsenic trioxide injection 59 imetelstat GRN#L 59 mGluR5 negative 59 include Alferon N